Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.

Vaccine - 9 Sept 2004

Beasley David W C, Li Li, Suderman Miguel T, Guirakhoo Farshad, Trent Dennis W, Monath Thomas P, Shope Robert E, Barrett Alan D T

Abstract excerpt

The ability of antisera raised against a candidate Japanese encephalitis virus (JEV) vaccine, ChimeriVax-JE, and the currently licensed vaccine, JE-VAX, to protect against strains of JEV representing the four major genotypes was assessed. Neutralization assays and passive protection studies in mice showed that greatest protection was provided against strains of genotypes II and III, although some protection was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Encephalitis, Japanese

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Encephalitis Virus, Japanese

Share to Immunization, Passive

Share to Mice, Inbred ICR

Share to Neutralization Tests

Share to Recombinant Fusion Proteins

Share to Survival Analysis

Source

Identifiers

PMID: 15315852
DOI: 10.1016/j.vaccine.2004.03.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.PMID 15315852Read ↗

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes.Semantic proximity Read ↗

Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice.Semantic proximity Read ↗

Immunogenicity, Genetic Stability, and Protective Efficacy of a Recombinant, Chimeric Yellow Fever-Japanese Encephalitis Virus (ChimeriVax-JE) as a Live, Attenuated Vaccine Candidate against Japanese EncephalitisSemantic proximity Read ↗

Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.Semantic proximity Read ↗

Partial cross-protection between Japanese encephalitis virus genotype I and III in miceSemantic proximity Read ↗

ChimeriVax-West Nile Virus Live-Attenuated Vaccine: Preclinical Evaluation of Safety, Immunogenicity, and EfficacySemantic proximity Read ↗

Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up studySemantic proximity Read ↗

Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4.Semantic proximity Read ↗

Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India.Semantic proximity Read ↗

Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus.Semantic proximity Read ↗

Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.Semantic proximity Read ↗

Molecular Basis for Attenuation of Neurovirulence of a Yellow Fever Virus/Japanese Encephalitis Virus Chimera Vaccine (ChimeriVax-JE)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.